Potential Clinical Application of Genomics in Multiple Myeloma
AbstractMultiple myeloma is a heterogeneous disease with different characteristics, and genetic aberrations play important roles in this heterogeneity. Studies have shown that these genetic aberrations are crucial in prognostication and response assessment; recent efforts have focused on their possible therapeutic implications. Despite many emerging studies being published, the best way to incorporate these results into clinical practice remains unclear. In this review paper we describe the different genomic techniques available, including the latest advancements, and discuss the potential clinical application of genomics in multiple myeloma. View Full-Text
Share & Cite This Article
Soekojo, C.Y.; de Mel, S.; Ooi, M.; Yan, B.; Chng, W.J. Potential Clinical Application of Genomics in Multiple Myeloma. Int. J. Mol. Sci. 2018, 19, 1721.
Soekojo CY, de Mel S, Ooi M, Yan B, Chng WJ. Potential Clinical Application of Genomics in Multiple Myeloma. International Journal of Molecular Sciences. 2018; 19(6):1721.Chicago/Turabian Style
Soekojo, Cinnie Y.; de Mel, Sanjay; Ooi, Melissa; Yan, Benedict; Chng, Wee J. 2018. "Potential Clinical Application of Genomics in Multiple Myeloma." Int. J. Mol. Sci. 19, no. 6: 1721.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.